拉帕科尔的三种多种类型,拉帕科尔是一种具有有前途的药理性质的天然色素
Natasha Di Benedetto1, Mario A Macías2, Noelia Méndez1
1Cryssmat-Lab/DETEMA, Facultad de Química, Universidad de la República, Av. Gral. Flores 2124, Montevideo 11800, Uruguay.
概括
拉帕科尔是一种具有药用用途的天然色素,表现出明显的晶体结构. 这些多态,不同于层叠,显示密度的微妙变化,影响其属性.
科学领域:
- 晶体学 晶体学是指结晶学.
- 材料科学 材料科学 材料科学
- 药用化学 医学化学
背景情况:
- 拉帕霍尔 (C15H14O3) 是一种具有显著生物和药理活动的天然色素.
- 它在传统医学和科学研究中都很重要.
- 了解其固态结构对于其应用至关重要.
研究的目的:
- 为了重新确定和比较拉帕科尔多态的晶体结构.
- 为了研究拉帕科尔晶体结构的多类型性质.
- 分析晶体结构变化与密度等物理性质之间的关系.
主要方法:
- 用X射线结晶学来确定晶体结构.
- 重新确定现有的多态形态,并确定一种新的形态.
- 结构特征的比较分析,包括结,π堆叠和层间安排.
主要成果:
- 确定了三种不同的lapachol多态,表现出三临床 (P1) 和单临床 (P21/c) 空间组.
- 所有结构都是多类型,其特点是二维的键层通过π堆叠连接在一起.
- 邻近的层被范德瓦尔斯力联系在一起,具有不同的堆叠模式 (转换,旋转),导致微妙的密度差异.
结论:
- 拉帕霍尔表现出多样性,层间堆叠模式的变化影响了晶体密度.
- 已识别的晶体结构为lapachol的固态行为提供了洞察力.
- 进一步的研究可以探索这些结构差异如何影响lapachol的生物活动和应用.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
645
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
645
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
134
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
134

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
![[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)